ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,806 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryWädenswilGlycoEra AG
GlycoEra AG Logo
Verified· 3 sources

GlycoEra AG

Summary

About the company

The core activity of GlycoEra is the development of innovative biologics based on a glycoengineering platform, particularly for the treatment of autoimmune diseases and neurological disorders through protein degradation.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered5
Development of Precision Therapeutics
Development of novel biologics for the selective removal of disease-causing proteins, with an initial focus on autoimmune diseases and other protein-driven conditions.
Protein Targeting and Degradation
Protein targeting and degradation of circulating extracellular and membrane proteins to remove disease-causing proteins quickly, deeply and selectively from circulation.
Autoimmune Disease Programs
Programs for the treatment of autoimmune diseases, in particular against circulating autoantibodies, with the first program GE8820 for pathogenic IgG4 autoantibodies.
Platform for Extracellular Protein Degraders
Platform for the development of bifunctional biologics for the degradation of extracellular and membrane-bound proteins; designed for fast, deep and selective target engagement.
Partnerships for Pipeline Development
Partnerships with industrial companies to expand the impact of the platform and to develop additional programs against circulating proteins.
Press

Media

May 27, 2025Media
GlycoEra AG raises $130 Million to advance therapies for autoimmune diseases
startupticker.ch
January 8, 2024Media
Bristol Myers Squibb invests in GlycoEra
startupticker.ch
January 19, 2021Media
LimmaTech launches spin-out for drug development
startupticker.ch

Knowledge

No knowledge articles yet

Once GlycoEra AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

GlycoEra AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank GlycoEra AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of GlycoEra AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Einsiedlerstrasse 34
8820 Wädenswil
Opening hours
Mon
09:00 - 16:00
Tue
09:00 - 16:00
Wed
09:00 - 16:00
Thu
09:00 - 16:00
Fri
09:00 - 16:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-477.046.648
Founded
2020 · 6 years
Last commercial register change
March 19, 2026
Employees
51 to 100

Similar companies

HG
HeiQ GrapheneX AG
Schlieren
LB
LimmaTech Biologics AG
Schlieren
SA
Selectchemie AG
Zurich
FP
Frike Pharma AG
Mönchaltorf